MM in the Know

A global education and awareness initiative that provides patients and caregivers with the information and resournces they need to live with multiple myeloma.

[MM in the Know @mmintheknow]

✏️MM Matters: Quick quiz

Which of the following is NOT an example of how BCMA-directed bispecific antibodies might differ?

💡Hint: Check out our recent educational module on bispecific antibodies before answering.

#MultipleMyeloma #myeloma #cancer #BloodCancer #MMMattersQuiz

[MM in the Know @mmintheknow]

Learn about new myeloma research from #IMS2026. Join a free MMRF webinar focused on key takeaways for patients, plus a live Q&A.

📅Wed, Sept. 30 | 5PM ET

Register: https://t.co/vBelXLDuib

[MM in the Know @mmintheknow]

✅ Target on myeloma cells. All BCMA-directed bispecific antibodies target the same protein on myeloma cells, called BCMA. However, they may differ in how they are given (for example, injection under the skin or infusion), how often they are given, where treatment is given, and which side effects are most common. Understanding these differences can help with shared decision-making.

[MM in the Know @mmintheknow]

✏️MM Matters: Quick quiz

Which of the following is NOT an example of how BCMA-directed bispecific antibodies might differ?

💡Hint: Check out our recent educational module on bispecific antibodies before answering.

#MultipleMyeloma #myeloma #cancer #BloodCancer #MMMattersQuiz

[MM in the Know @mmintheknow]

If you have been treated with a bispecific antibody for multiple myeloma, which of the following has been your main treatment to help prevent infections?

#MultipleMyeloma #myeloma #cancer #BloodCancer

[MM in the Know @mmintheknow]

Treatment decisions in #MultipleMyeloma should be made together by patients and their care team.

Watch our latest video, featuring Professor Mohty, on shared decision-making in multiple myeloma.

Watch the full video here: https://t.co/2raw67101j

👍 Like this post if you learned something new
🔁 Share it with friends or colleagues who may also find it helpful

#myeloma #cancer #BloodCancer #PatientEducation

[@MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher]

What does shared decision-making mean in multiple myeloma? https://t.co/3TkPS3dFII @mmintheknow #mmsm #myeloma @Mohty_EBMT

[MM in the Know @mmintheknow]

September is #BloodCancerAwarenessMonth! This month, we're shining a light on #myeloma — one of the three primary forms of blood cancer.

Visit https://t.co/EzV0Jdt17F, where we provide patients and caregivers with up-to-date, reliable information on #MultipleMyeloma.

#mmintheknow

[MM in the Know @mmintheknow]

Some bispecific antibody therapies are given through an infusion into a vein, while others are injected under the skin.

Find out more about how each bispecific antibody for Multiple Myeloma is different and key questions to discuss with your healthcare team to ensure your treatment plan is right for you.

👍 Like this post if you learned something new
🔁 Share it with friends or colleagues who may also find it helpful

Top tip: to learn more about the side effects of bispecific antibodies, check out our recent infographic!

[MM in the Know @mmintheknow]

If all were possible, how often would you prefer to receive your treatment for multiple myeloma?

#MultipleMyeloma #myeloma #mmsm #cancer #BloodCancer

[MM in the Know @mmintheknow]

Endurance athlete Eric Gelber has spent 20 years pushing his physical limits to fund multiple myeloma research. He's back at it with another ambitious fitness challenge.

[Multiple Myeloma RF @theMMRF]

In 1 month, endurance athlete and MMRF supporter Eric Gelber takes on his most relentless challenge yet: 36 hours. 10,000 pushups. 100 miles rowed.

Join us 9/26 at the Chappaqua NY Train Station, follow the journey on social, and support: https://t.co/a9PPdX4FnX

[MM in the Know @mmintheknow]

Les choix de traitement dans le #MyélomeMultiple doivent refléter à la fois les meilleurs soins médicaux ainsi que les préférences et les besoins du patient.

Découvrez notre dernière vidéo avec le Professeur Mohty sur ce que signifie réellement la prise de décision partagée dans le myélome multiple.

https://t.co/1VSGLdnt5u

👍 Aimez cette publication si vous avez appris quelque chose de nouveau
🔁 Partagez-la avec des amis ou des collègues qui pourraient également la trouver utile

#myélome #cancer #CancerDuSang #ÉducationDesPatients

[MM in the Know @mmintheknow]

Las decisiones de tratamiento en el #MielomaMúltiple deben reflejar tanto la mejor atención médica como las preferencias y necesidades del paciente.

Vea nuestro último vídeo con el Profesor Mohty sobre lo que significa realmente la toma de decisiones compartida en el mieloma múltiple.

https://t.co/83jNL0PV3P

👍 Indique que le gusta esta publicación si ha aprendido algo nuevo
🔁 Compártala con amigos o compañeros que también puedan encontrarla útil

#mieloma #cáncer #CáncerDeLaSangre #EducaciónDelPaciente

[MM in the Know @mmintheknow]

Il trattamento del #MielomaMultiplo dovrebbe contemperare la migliore assistenza medica con le preferenze e le esigenze del paziente.

Guarda il nostro ultimo video con il Professor Mohty per capire cosa significa realmente il processo decisionale condiviso nel mieloma multiplo.

https://t.co/BzcS8ykYi7

👍 Metti "Mi piace" a questo post se hai imparato qualcosa di nuovo
🔁 Condividilo con amici o colleghi che potrebbero trovarlo utile

#mieloma #cancro #TumoreDelSangue #EducazioneDelPaziente

[MM in the Know @mmintheknow]

Die Behandlungsentscheidungen beim #MultiplenMyelom sollten sowohl die bestmögliche medizinische Versorgung als auch die Präferenzen und Bedürfnisse der Patientinnen und Patienten berücksichtigen.

Sehen Sie sich unser neuestes Video mit Professor Mohty an und erfahren Sie, was gemeinsame Entscheidungsfindung beim Multiplen Myelom wirklich bedeutet.

https://t.co/8Cw0M7YEQy

👍 Liken Sie diesen Beitrag, wenn Sie etwas Neues gelernt haben
🔁 Teilen Sie ihn mit Freunden oder Kolleginnen und Kollegen, die ihn ebenfalls hilfreich finden könnten

#Myelom #Krebs #Blutkrebs #Patientenaufklärung

[MM in the Know @mmintheknow]

https://t.co/bBiVnarcbk

[MM in the Know @mmintheknow]

✏️MM Matters: Quick quiz

Which of the following is NOT an example of how BCMA-directed bispecific antibodies might differ?

💡 Hint: Check out our recent educational module on bispecific antibodies before answering.

#MultipleMyeloma #myeloma #cancer #BloodCancer #MMMattersQuiz

[MM in the Know @mmintheknow]

Bispecific antibodies all work in a similar way, but they target different proteins (which act like markers). They also differ in how they are given, how often they are given, and the side effects they can cause.

Explore our mini-module to learn more about the key similarities and differences between bispecific antibodies for #MultipleMyeloma.

👍 Like this post if you learned something new

🔁 Share it with friends or colleagues who may also find it helpful

Top tip: to learn more about the side effects of bispecific antibodies, check out our recent infographic!

#myeloma #cancer #BloodCancer #PatientEducation

[MM in the Know @mmintheknow]

https://t.co/NzHs86JkdU

[MM in the Know @mmintheknow]

Bispecific antibodies all work in a similar way, but they target different proteins (which act like markers). They also differ in how they are given, how often they are given, and the side effects they can cause.

Explore our mini-module to learn more about the key similarities and differences between bispecific antibodies for #MultipleMyeloma.

👍 Like this post if you learned something new

🔁 Share it with friends or colleagues who may also find it helpful

Top tip: to learn more about the side effects of bispecific antibodies, check out our recent infographic!

#myeloma #cancer #BloodCancer #PatientEducation

[MM in the Know @mmintheknow]

✏️MM Matters: Quick quiz

Which of the following is NOT an example of how BCMA-directed bispecific antibodies might differ?

💡 Hint: Check out our recent educational module on bispecific antibodies before answering.

#MultipleMyeloma #myeloma #cancer #BloodCancer #MMMattersQuiz

[MM in the Know @mmintheknow]

If you have been treated with a bispecific antibody for multiple myeloma, which of the following has been your main treatment to help prevent infections?

#MultipleMyeloma #myeloma #cancer #BloodCancer

[MM in the Know @mmintheknow]

Les anticorps bispécifiques sont un type d'immunothérapie utilisé pour le #MultipleMyeloma. Ils agissent en aidant le système immunitaire à reconnaître et à attaquer les cellules cancéreuses.

Explorez notre mini-module pour en savoir plus sur les anticorps bispécifiques, leur mode d'action et ce à quoi s'attendre du traitement.

👍 Aimez cette publication si vous avez appris quelque chose de nouveau

🔁 Partagez-la avec des amis ou des collègues qui pourraient également la trouver utile

#myeloma #cancer #BloodCancer #PatientEducation